Biotechnology in Medicine — Vaccines, Biosimilars & Gene Therapy

Preparation should focus on balancing technical definitions with their socio-economic impact on India's healthcare landscape. Answers must bridge the gap between scientific innovation, such as mRNA platforms or CRISPR, and regulatory frameworks like the New Drugs and Clinical Trials Rules. Success in GS3 requires linking these technologies to self-reliance (Atmanirbhar Bharat) and global health equity.